Advanced search
Publication Cover
Current Medical Research and Opinion Volume 38, 2022 - Issue 12
Submit an article Journal homepage
559
Views
2
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis

Alpesh Amina University of California, Irvine, Irvine, CA, USACorrespondence[email protected]
,
Allison Keshishianb STATinMED Research, Ann Arbor, MI, USA
,
Dionne M. Hinesc Pfizer Inc., New York, NY, USA
,
Oluwaseyi Dinac Pfizer Inc., New York, NY, USA
,
Hannah Led Bristol-Myers Squibb, Lawrenceville, NJ, USA
,
Lisa Rosenblattd Bristol-Myers Squibb, Lawrenceville, NJ, USA
,
Xianchen Liuc Pfizer Inc., New York, NY, USA
,
Qisu Zhangb STATinMED Research, Ann Arbor, MI, USA
&
Lien Vod Bristol-Myers Squibb, Lawrenceville, NJ, USA
 show all
Pages 2131-2140 | Received 04 May 2022, Accepted 17 Aug 2022, Published online: 30 Aug 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

William L. Baker, Matthew S. Roberts, Youssef Bessada, Kimberly S. Caroti, Veronica Ashton, Brahim K. Bookhart & Craig I. Coleman. (2023) Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies. Current Medical Research and Opinion 39:9, pages 1183-1194.
Read now

Articles from other publishers (1)

Q. Samaran, M. Lacombe, O. Cogrel, M. Chapalain, A. Le Guern & F. Habib. (2023) Peri‐operative management of direct Xa and IIa inhibitors for dermatologic surgery: A survey of current practice among French dermatologists . Journal of the European Academy of Dermatology and Venereology 37:9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.